Connection

Peter Kalivas to Rats, Inbred Strains

Back to Details
This is a "connection" page, showing publications Peter Kalivas has written about Rats, Inbred Strains.
Peter Kalivas
Connection Strength
1.232
Rats, Inbred Strains
  1. Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer. J Neurosci. 2001 Nov 15; 21(22):9043-52.
    View in: PubMed
    Score: 0.046
  2. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci. 1992 Jul; 12(7):2623-32.
    View in: PubMed
    Score: 0.024
  3. Modulation of extracellular gamma-aminobutyric acid in the ventral pallidum using in vivo microdialysis. J Neurochem. 1992 Jun; 58(6):2311-20.
    View in: PubMed
    Score: 0.024
  4. Patterns of glucose use after bicuculline-induced convulsions in relationship to gamma-aminobutyric acid and mu-opioid receptors in the ventral pallidum--functional markers for the ventral pallidum. Brain Res. 1992 May 22; 581(1):39-45.
    View in: PubMed
    Score: 0.024
  5. Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res. 1992 May 08; 579(2):181-6.
    View in: PubMed
    Score: 0.024
  6. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation. Synapse. 1992 May; 11(1):47-57.
    View in: PubMed
    Score: 0.024
  7. Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity. J Pharmacol Exp Ther. 1992 May; 261(2):811-8.
    View in: PubMed
    Score: 0.024
  8. Apomorphine decreases extracellular GABA in the ventral pallidum of rats with 6-OHDA lesions in the nucleus accumbens. Brain Res. 1992 Apr 17; 577(2):306-11.
    View in: PubMed
    Score: 0.023
  9. Pertussis toxin in the A10 region increases dopamine synthesis and metabolism. J Neurochem. 1992 Mar; 58(3):811-6.
    View in: PubMed
    Score: 0.023
  10. The role of the nucleus accumbens in sensitization to drugs of abuse. Prog Neuropsychopharmacol Biol Psychiatry. 1992 Mar; 16(2):237-46.
    View in: PubMed
    Score: 0.023
  11. Autoradiographic localization of gamma-aminobutyric acidA receptors within the ventral tegmental area. Neurochem Res. 1992 Jan; 17(1):101-6.
    View in: PubMed
    Score: 0.023
  12. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology. 1991 Dec; 30(12A):1269-74.
    View in: PubMed
    Score: 0.023
  13. Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J Pharmacol Exp Ther. 1991 Nov; 259(2):916-24.
    View in: PubMed
    Score: 0.023
  14. Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res. 1991 Sep 13; 559(1):29-36.
    View in: PubMed
    Score: 0.023
  15. Effects of d-amphetamine injected into the nucleus accumbens on ethanol reinforced behavior. Brain Res Bull. 1991 Aug; 27(2):267-71.
    View in: PubMed
    Score: 0.022
  16. GABAA receptors containing alpha 1 and beta 2 subunits are mainly localized on neurons in the ventral pallidum. Synapse. 1991 Jun; 8(2):75-85.
    View in: PubMed
    Score: 0.022
  17. Possible role for G-proteins in behavioral sensitization to cocaine. Brain Res. 1991 Apr 05; 545(1-2):287-91.
    View in: PubMed
    Score: 0.022
  18. A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem. 1991 Mar; 56(3):961-7.
    View in: PubMed
    Score: 0.022
  19. Dopaminergic involvement in locomotion elicited from the ventral pallidum/substantia innominata. Brain Res. 1991 Feb 22; 542(1):123-31.
    View in: PubMed
    Score: 0.022
  20. GABAergic and enkephalinergic regulation of locomotion in the ventral pallidum: involvement of the mesolimbic dopamine system. Adv Exp Med Biol. 1991; 295:315-26.
    View in: PubMed
    Score: 0.021
  21. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J Neurosci. 1990 Sep; 10(9):2940-9.
    View in: PubMed
    Score: 0.021
  22. Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis. J Pharmacol Exp Ther. 1990 Aug; 254(2):711-9.
    View in: PubMed
    Score: 0.021
  23. Amphetamine lowers extracellular GABA concentration in the ventral pallidum. Brain Res. 1990 May 14; 516(1):132-6.
    View in: PubMed
    Score: 0.021
  24. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J Pharmacol Exp Ther. 1990 May; 253(2):858-66.
    View in: PubMed
    Score: 0.020
  25. Changes in gamma-aminobutyric acid, mu-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens. Brain Res. 1990 Mar 12; 511(1):41-54.
    View in: PubMed
    Score: 0.020
  26. Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum. J Pharmacol Exp Ther. 1990 Mar; 252(3):1370-7.
    View in: PubMed
    Score: 0.020
  27. Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine]enkephalin (125I-DPDPE). Synapse. 1990; 6(2):121-32.
    View in: PubMed
    Score: 0.020
  28. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse. 1990; 5(1):48-58.
    View in: PubMed
    Score: 0.020
  29. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther. 1989 Oct; 251(1):378-87.
    View in: PubMed
    Score: 0.020
  30. Blockade of enkephalinergic and GABAergic mediated locomotion in the nucleus accumbens by muscimol in the ventral pallidum. Jpn J Pharmacol. 1989 Aug; 50(4):487-90.
    View in: PubMed
    Score: 0.019
  31. Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res. 1989 May 29; 488(1-2):311-27.
    View in: PubMed
    Score: 0.019
  32. Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 dopamine region. Neurosci Lett. 1989 May 22; 100(1-3):215-20.
    View in: PubMed
    Score: 0.019
  33. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol Psychiatry. 1989 Apr 01; 25(7):913-28.
    View in: PubMed
    Score: 0.019
  34. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther. 1988 Jun; 245(3):1095-102.
    View in: PubMed
    Score: 0.018
  35. Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J Neurochem. 1988 May; 50(5):1498-504.
    View in: PubMed
    Score: 0.018
  36. The effect of cholinergic stimulation in the nucleus accumbens on locomotor behavior. Brain Res. 1988 Feb 16; 441(1-2):209-14.
    View in: PubMed
    Score: 0.018
  37. Behavioral cross-sensitization between cocaine and enkephalin in the A10 dopamine region. Behav Brain Res. 1988 Jan; 27(1):87-91.
    View in: PubMed
    Score: 0.017
  38. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther. 1987 Sep; 242(3):757-63.
    View in: PubMed
    Score: 0.017
  39. Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine. Brain Res. 1987 Jun 30; 414(2):339-48.
    View in: PubMed
    Score: 0.017
  40. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J Pharmacol Exp Ther. 1987 Apr; 241(1):328-37.
    View in: PubMed
    Score: 0.017
  41. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J Pharmacol Exp Ther. 1987 Apr; 241(1):204-12.
    View in: PubMed
    Score: 0.017
  42. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens. J Pharmacol Exp Ther. 1986 Sep; 238(3):1126-31.
    View in: PubMed
    Score: 0.016
  43. Endogenous enkephalin modulation of dopamine neurons in ventral tegmental area. Am J Physiol. 1986 Aug; 251(2 Pt 2):R243-9.
    View in: PubMed
    Score: 0.016
  44. Cross-sensitization between foot shock stress and enkephalin-induced motor activity. Biol Psychiatry. 1986 Aug; 21(10):939-50.
    View in: PubMed
    Score: 0.016
  45. Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area. Brain Res. 1985 Dec 09; 358(1-2):70-6.
    View in: PubMed
    Score: 0.015
  46. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization. J Pharmacol Exp Ther. 1985 Nov; 235(2):537-43.
    View in: PubMed
    Score: 0.015
  47. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system. J Pharmacol Exp Ther. 1985 Nov; 235(2):544-50.
    View in: PubMed
    Score: 0.015
  48. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin. Neuropharmacology. 1985 Oct; 24(10):931-6.
    View in: PubMed
    Score: 0.015
  49. Substance K and substance P in the ventral tegmental area. Neurosci Lett. 1985 Jun 24; 57(3):241-6.
    View in: PubMed
    Score: 0.015
  50. A catecholaminergic projection from the ventral tegmental area to the diagonal band of Broca: modulation by neurotensin. Brain Res. 1985 Feb 11; 326(2):229-38.
    View in: PubMed
    Score: 0.014
  51. Microinjection of neurotensin into the ventral tegmental area produces hypothermia: evaluation of dopaminergic mediation. Brain Res. 1985 Feb 11; 326(2):219-27.
    View in: PubMed
    Score: 0.014
  52. Dopamine microinjection into the nucleus accumbens: correlation between metabolism and behavior. Biochem Pharmacol. 1985 Jan 15; 34(2):284-6.
    View in: PubMed
    Score: 0.014
  53. Substance P modulation of the mesolimbic dopamine system. Prog Clin Biol Res. 1985; 192:403-8.
    View in: PubMed
    Score: 0.014
  54. Substance P modulation of dopamine in the nucleus accumbens. Neurosci Lett. 1984 Jul 13; 48(1):55-9.
    View in: PubMed
    Score: 0.014
  55. Neurotensin in the ventromedial mesencephalon of the rat: anatomical and functional considerations. J Comp Neurol. 1984 Jul 10; 226(4):495-507.
    View in: PubMed
    Score: 0.014
  56. Neurotensin neurons in the ventral tegmental area project to the medial nucleus accumbens. Brain Res. 1984 May 21; 300(1):157-60.
    View in: PubMed
    Score: 0.014
  57. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing. Neuroscience. 1984 Apr; 11(4):919-30.
    View in: PubMed
    Score: 0.013
  58. Evidence for interactions of endogenous peptides with the mesolimbic dopamine system. Psychopharmacol Bull. 1984; 20(3):354-7.
    View in: PubMed
    Score: 0.013
  59. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther. 1983 Oct; 227(1):229-37.
    View in: PubMed
    Score: 0.013
  60. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience. 1983 Mar; 8(3):495-505.
    View in: PubMed
    Score: 0.012
  61. Antinociception after microinjection of neurotensin into the central amygdaloid nucleus of the rat. Brain Res. 1982 Jul 15; 243(2):279-86.
    View in: PubMed
    Score: 0.012
  62. Histamine-induced arousal in the conscious and pentobarbital-pretreated rat. J Pharmacol Exp Ther. 1982 Jul; 222(1):37-42.
    View in: PubMed
    Score: 0.012
  63. Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. Eur J Pharmacol. 1982 Mar 26; 78(4):471-4.
    View in: PubMed
    Score: 0.012
  64. Increase in spontaneous motor activity following infusion of neurotensin into the ventral tegmental area. Brain Res. 1981 Dec 21; 229(2):525-9.
    View in: PubMed
    Score: 0.011
  65. Effect of septohippocampal lesions on thyrotropin-releasing hormone antagonism of pentobarbital narcosis. Brain Res. 1981 Oct 19; 222(2):253-65.
    View in: PubMed
    Score: 0.011
  66. Autoradiographic localization of angiotensin II receptor binding sites on noradrenergic neurons of the locus coeruleus of the rat. J Neurochem. 1990 Aug; 55(2):533-40.
    View in: PubMed
    Score: 0.005
  67. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res. 1987 Aug 04; 417(1):51-8.
    View in: PubMed
    Score: 0.004
  68. Cholecystokinin-induced suppression of locomotion is attenuated in capsaicin pretreated rats. Peptides. 1986 Jul-Aug; 7(4):587-90.
    View in: PubMed
    Score: 0.004
  69. Possible involvement of serotonergic neurotransmission in neurotensin but not morphine analgesia. Brain Res. 1984 Sep 17; 310(1):35-41.
    View in: PubMed
    Score: 0.003
  70. Bombesin-induced locomotor hyperactivity: evaluation of the involvement of the mesolimbic dopamine system. Brain Res. 1984 Jun 25; 304(2):377-82.
    View in: PubMed
    Score: 0.003
  71. Influence of cholecystokinin on central monoaminergic pathways. Regul Pept. 1983 May; 6(2):99-109.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.